Genedrive PLC Director/PDMR Shareholding (0927V)

TIDMGDR

RNS Number : 0927V

Genedrive PLC

19 July 2018

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

genedrive plc (LSE: GDR) ("genedrive" or the "Company"), the near patient molecular diagnostics company, announces that it on 17 July 2018 share options ("Options") were granted to certain of its directors to acquire a total of 486,306 ordinary shares of 1.5p each in the capital of the Company under the Company's 2017 Share Option Scheme.

The Options have been granted with an exercise price equal to the closing price on the day before grant and vest after a period of three years if certain performance criteria are met. The Options are exercisable over the period of 10 years from the date of grant.

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 
            1.   Details of the person discharging managerial responsibilities 
                  / person closely associated 
      a.         Name                                       1. David Budd 
                                                             2. Matthew Fowler 
                ------------------------------  ---------------------------------------------------------- 
            2.   Reason for the notification 
                ------------------------------------------------------------------------------------------ 
            a.   Position/status                            1. CEO 
                                                             2. CFO 
                ------------------------------  ---------------------------------------------------------- 
            a.   Initial notification            Initial notification 
                  /Amendment 
                ------------------------------  ---------------------------------------------------------- 
      3.         Details of the issuer, emission allowance market participant, 
                  auction platform, auctioneer or auction monitor 
                ------------------------------------------------------------------------------------------ 
            a.   Name                            genedrive plc 
                ------------------------------  ---------------------------------------------------------- 
            b.   LEI                             213800ZYODIRZ87Y4K14 
                ------------------------------  ---------------------------------------------------------- 
            4.   Details of the transaction(s): section to be repeated for 
                  (i) each type of instrument; (ii) each type of transaction; 
                  (iii) each date; and (iv) each place where transactions 
                  have been conducted 
                ------------------------------------------------------------------------------------------ 
            a.   Description of                  Options over ordinary shares of 1.5 pence 
                  the                             each 
                  Financial instrument, 
                  type 
                  of instrument 
                  Identification 
                  code 
                ------------------------------  ---------------------------------------------------------- 
            b.   Nature of the                              Grant of options pursuant to and in accordance 
                  transaction                                with the terms of the Company's Share Option 
                                                             Scheme dated 5 December 2017. 
                ------------------------------  ---------------------------------------------------------- 
            c.   Price(s) and                      Price(s)                  Option   Volume(s) 
                  volume(s)                                                 price(s) 
                                                         David Budd          30.5p       222,260 
                                                                          ----------  ---------- 
                                                         Matthew Fowler      30.5p       264,046 
                                                                          ----------  ---------- 
                ------------------------------  ---------------------------------------------------------- 
            d.        Aggregated information 
                        *    Aggregated volume     N/A 
 
 
                        *    Price 
                ------------------------------  ---------------------------------------------------------- 
            e.   Date of the transaction         2018-17-07; UTC time 
                ------------------------------  ---------------------------------------------------------- 
            f.   Place of the                    Outside trading venue - shares to be admitted 
                  transaction                     to AIM market of London Stock Exchange plc 
                                                  on exercise of options 
                ------------------------------  ---------------------------------------------------------- 
 

For further details please contact:

 
 genedrive plc                           [phone] 
 David Budd: CEO 
 Matthew Fowler: CFO 
 
   Peel Hunt LLP                         [phone] 
 James Steel 
 Oliver Jackson 
 
   Stanhope Capital Ltd                  [phone] 
 Patrick Claridge 
 
   Consilium Strategic Communications    [phone] 
 Chris Gardner 
 Matthew Neal 
 Laura Thornton 
 [e-mail] 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHEANXPFFDPEFF

(END) Dow Jones Newswires

July 19, 2018 02:00 ET (06:00 GMT)